Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-680-0 | CAS number: 17691-19-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Acute Oral Toxicity:
The lethal concentration (LD50) value for acute oral toxicity test was considered to be >5000 mg/kg bw ,when 5 male and 5 female Wistar (SPF cpB) rats were treated with Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9) orally. Thus, comparing this value with the criteria of CLPregulation,Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9)can be “Not classified” for Acute Oral Toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- data is from experimental reports
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Acute Oral toxicity test was carried out to study the effects of Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9) on rats.
- GLP compliance:
- not specified
- Test type:
- other: no data available
- Limit test:
- no
- Specific details on test material used for the study:
- - Name of test material (as cited in study report):sodium 4–chloro–3–nitrobenzenesulphonate
- Molecular formula :C6H4NNaO5S
- Molecular weight :225.1556 g/mol
- Substance type:organic - Species:
- rat
- Strain:
- other: Wistar (SPF cpB)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Details on test animal:
TEST ANIMALS:
- Source: winkelmann, Borchen
- Age at study initiation: 14 weeks old avg.
- Weight at study initiation: Initial weight of male animals was 161 g and the female rats had an average initial weight of 160 g.
- Fasting period before study: No data available
- Housing: The rats were kept conventionally in Makrolonkaefigen type III on dust-free wood granules in groups of 5 each animals.
- Diet (e.g. ad libitum): the feed : Altromin R 1324 was given ad libitum
- Water (e.g. ad libitum): water was provided ad libitum for approximately 16 hours and before until about 4 hours after application.
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 1.5 degrees Celsius
- Humidity (%):approx. 60 +/- 5%
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): 2 hours of light / dark rhythm (artificial Lighting from 7 am to 7 pm CET)
IN-LIFE DATES: From: To: 25.8.1980 to 8.9.1980 - Route of administration:
- oral: unspecified
- Vehicle:
- water
- Details on oral exposure:
- Details on exposure:
VEHICLE
- Concentration in vehicle:5000mg/kg bw
- Amount of vehicle (if gavage): 20 ml/kg bw
- Justification for choice of vehicle: test substance was soluble in water
DOSAGE PREPARATION (if unusual): The substance was formulated in water using a rigid metal stomach probe in koaslantem - Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- Total : 10 animals
5000 mg/kg bw :5 males and 5 females - Control animals:
- not specified
- Details on study design:
- Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of weighing: after 1 week and at the end of the
14 days animals were weighed individually.
- Necropsy of survivors performed: yes
- Other examinations performed: Clinical signs - Statistics:
- No data available
- Preliminary study:
- No data available
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality was observed in treated rats at 5000 mg/kg bw
- Mortality:
- No mortality was observed in treated rats at 5000 mg/kg bw
- Clinical signs:
- other: No poisoning symptoms were observed
- Gross pathology:
- The section of some animals killed at the end of the experiment showed no macroscopic findings.
- Other findings:
- No data available
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- The lethal concentration (LD50) value for acute oral toxicity test was considered to be >5000 mg/kg bw ,when 5 male and 5 female Wistar (SPF cpB) rats were treated with Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9) orally.
- Executive summary:
Acute oral toxicity study was done in 5 male and 5 female Wistar (SPF cpB)rats using test material Sodium 4-chloro-3-nitrobenzenesulphonate(17691-19-9) following 14 days of observation period.Rats were 14 weeks old.Initial weight of male animals was 161 g and the female rats had an average initial weight of 160 g. The rats were conventionally kept in Makrolonkaefigen type III on dust-free wood granules at a room temperature of 22 +/- 1.5 degrees Celsius and 2 hours of light / dark rhythm (artificial lighting from 7 am to 7 pm CET) and a relative humidity of approx. 60 +/- 5% in groups of 5 each animals.The feed,Altromin R 1324 was given ad libitum. Water was provided ad libitum for approximately 16 hours and before until about 4 hours after application.Water was used as vehicle.The substance was formulated in water using a rigid metal stomach probe in koaslantem. Application volume (20 ml / kg body weight) to each 5
males and 5 females were given once. After 1 week and at the end of the 14 days animals were weighed individually.No mortality was observed at dose 5000 mg/kg bw.No poisoning symptoms were observed in animals.The section of some animals killed at the end of the experiment showed no macroscopic findings.Hence,LD50 value was considered to be >5000 mg/kg bw,when rats were treated withSodium 4-chloro-3-nitrobenzenesulphonate(17691-19-9) orally.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimicsh 2 and data is from experimental report
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute Oral Toxicity:
In different studies, Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9)has been investigated for acute oral toxicity to a greater or lesser extent. Often the studies are based on in vivo experiments and estimated data in rodents, i.e. most commonly in rats for Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9).
In an experimental study conducted by Sustainability Support Services (Europe) AB (Institute of Toxicology,wuppertal,1982-07-29,Report no. T8014021) for the target substance Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9). Acute oral toxicity study was done in 5 male and 5 female Wistar (SPF cpB)rats using test material Sodium 4-chloro-3-nitrobenzenesulphonate(17691-19-9) following 14 days of observation period.Rats were 14 weeks old.Initial weight of male animals was 161 g and the female rats had an average initial weight of 160 g. The rats were conventionally kept in Makrolonkaefigen type III on dust-free wood granules at a room temperature of 22 +/- 1.5 degrees Celsius and 2 hours of light / dark rhythm (artificial lighting from 7 am to 7 pm CET) and a relative humidity of approx. 60 +/- 5% in groups of 5 each animals.The feed,Altromin R 1324 was given ad libitum. Water was provided ad libitum for approximately 16 hours and before until about 4 hours after application.Water was used as vehicle.The substance was formulated in water using a rigid metal stomach probe in koaslantem. Application volume (20 ml / kg body weight) to each 5 males and 5 females were given once. After 1 week and at the end of the 14 days animals were weighed individually.No mortality was observed at dose 5000 mg/kg bw.No poisoning symptoms were observed in animals.The section of some animals killed at the end of the experiment showed no macroscopic findings.Hence,LD50 value was considered to be >5000 mg/kg bw,when rats were treated with Sodium 4-chloro-3-nitrobenzenesulphonate(17691-19-9) orally.
In another experimental study conducted by European Chemicals Bureau (ECB)( IUCLID DATASET, European Chemicals Bureau (ECB), 18–FEB–2000) for the target substance Sodium 4-Chloro-3-Nitrobenzenesulphonate (17691-19-9). Acute oral toxicity study was done in rats using test material Sodium 4-Chloro-3-Nitrobenzenesulphonate (17691-19-9).No mortality was observed at dose 5000 mg/kg bw. Hence,LD50 value was considered to be >5000 mg/kg bw,when rats were treated with Sodium 4-Chloro-3-Nitrobenzenesulphonate (17691-19-9)orally.
Also these results are further supported by the experimental study conducted by U.S. National Library of Medicine (Chemidplus Database,U.S. National Library of Medicine,2017) and IFA GESTIS (GESTIS SUBSTANCE Database ,2017) for the structurally similar read across substance Sodium 3-nitrobenzenesulphonate (127-68-4). Acute oral toxicity study was done in rats using test material Sodium 3-nitrobenzenesulphonate(127-68-4).50% mortality was observed at dose 11000 mg/kg bw. Hence,LD50 value was considered to be 11000 mg/kg bw,when rats were treated with Sodium 3-nitrobenzenesulphonate (127-68-4)orally.
Thus, based on the above studies and predictions on Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9) and its structurally similar read across substances, it can be concluded that LD50 value was >5000 mg/kg bw.Thus,comparing this value with the criteria of CLPregulation,Sodium 4-chloro-3-nitrobenzenesulphonate (17691-19-9) can be “Not classified” for Acute Oral Toxicity.
Justification for classification or non-classification
Thus, comparing this value with the criteria of CLPregulation,Sodium 4-chloro-3-nitrobenzenesulphonate(17691-19-9) can be “Not classified” for Acute Oral Toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
